Ovarian cancer immunotherapy of NF-κB may have a dark side
- PMID: 33515361
- DOI: 10.1007/s13577-021-00490-7
Ovarian cancer immunotherapy of NF-κB may have a dark side
References
-
- El-Arabey AA, Abdalla M, Abd-Allah AR. GATA3 and stemness of high-grade serous ovarian carcinoma: novel hope for the deadliest type of ovarian cancer. Hum Cell. 2020;1:904–6. - DOI
-
- Liu D, Zhang XX, Li MC, Cao CH, Wan DY, Xi BX, et al. C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation. Nat Commun. 2018;9(1):1739. - DOI
-
- Ghoneum A, Afify H, Salih Z, Kelly M, Said N. Role of tumor microenvironment in ovarian cancer pathobiology. Oncotarget. 2018;9(32):22832–49. - DOI
-
- Langley RR, Fidler IJ. The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 2011;128:2527–35. - DOI
-
- Colvin EK. Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol. 2014;6(4):137.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical